Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Opus Medical

Request full access

Opus Medical designs and manufactures tissue-to-bone and tissue-to tissue repair systems

San Juan Capistrano, United StatesFounded 1999Health Tech & Medtech

About Opus Medical

Opus Medical, established in 2014, specializes in the design, production, and distribution of motion management solutions for radiation therapy and medical imaging procedures. The company's creation was the culmination of 15 years of dedicated research conducted at Stanford University and the University of Sydney, positioning it on a strong scientific foundation. Headquartered within the Cicada Innovations incubator in Sydney, Australia, all of its medical devices are manufactured locally.

The company's core business revolves around providing safe and effective tools that assist healthcare professionals during radiation treatments and diagnostic imaging. By focusing on motion management, Opus Medical addresses the critical need to minimize patient movement to ensure the accuracy and efficacy of these procedures. The business operates in the global medical device market, serving clients in the healthcare sector, specifically hospitals and clinics that offer oncology and radiology services. Revenue is generated through the sale of its proprietary medical devices. Opus Medical has secured the necessary regulatory approvals for its products, including FDA registration in the United States, CE marking for Europe, and TGA approval in Australia, allowing for clinical use in these key markets.

While specific details about the founders are not publicly available, the company emphasizes its foundation in extensive academic research, highlighting a commitment to evidence-based solutions. The leadership team fosters a diverse and collaborative environment, bringing together expertise from various fields such as research, design, manufacturing, sales, and management. This multidisciplinary approach enables the company to navigate the complexities of the medical device industry, from initial concept to commercialization and post-market support.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
23.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Tissue Engineering, Hard Tech
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Jun 2003 $14M $54M Prospect Venture Partners —
SERIES B✓Equity / VC Jul 2002 $6.5M $26M Three Arch Partners —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearEBITDAMarginProfitMargin
2026 — —
2025 — —
2024 — —
2023 — —
2022 — —
2021 — —
2020 — —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Opus Medical website traffic

Latest recorded traffic for Opus Medical is 920 monthly website visits, up 37.3% over the last three months. Opus Medical's team grew 0% over the past year.

Latest monthly visits920 3-month web change+37.3% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Opus Medical in the San Juan Capistrano ecosystem

Live from Dealroom

The Opus Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Three Arch Partners

Series B and later1 investor entered at this stage

  • Prospect Venture Partners

Other known investors1 additional known investor

  • Artesian Capital Management
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Juan Capistrano HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Opus Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Opus Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.